http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef6f558021b8f64b3aecb3380a3557c7
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Rini |
| name | Brian Rini |
| given-name | Brian |
| organization-name | ‡Department of Solid Tumor, Taussig Cancer Center, Cleveland Clinic Foundation, Cleveland, OH 44195; and 2Department of Solid Tumor Oncology, Taussig Cancer Institute, and Authors' Affiliations: 1Hospital de la Santa Creu i San Pau, Barcelona, Spain and 2Department of Solid Tumor Oncology, Cleveland Clinic Taussig Cancer Institute, Glickman Urological Institute, Cleveland, Ohio Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA Department of Solid Tumor Oncology, Cleveland Clinic, Cleveland, Ohio, USA; Department of Hematology & Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA Department of Medicine, Division of Hematology and Oncology Vanderbilt University Medical Center Nashville Tennessee Thomas Powles, Royal Free Hospital, and Queen Mary University of London, London, United Kingdom; and Brian Rini, Lerner College of Medicine, and Cleveland Clinic, Cleveland, OH. Cleveland Clinic, Cleveland, Ohio Authors' Affiliations: 1Department of Immunology, 2Taussig Cancer Institute, and 3Glickman Urological Institute, Cleveland Clinic; 4Department of Pathology and 5Division of Hematology-Oncology, Case Western Reserve University; and 6Case Comprehensive Cancer Center, Cleveland, Ohio; and 7Division of Hematology and Oncology, Mayo Clinic Arizona, Scottsdale, Arizona; Authors' Affiliations: 1Department of Immunology, 2Taussig Cancer Institute, and 3Glickman Urological Institute, Cleveland Clinic; 4Department of Pathology and 5Division of Hematology-Oncology, Case Western Reserve University; and 6Case Comprehensive Cancer Center, Cleveland, Ohio; and 7Division of Hematology and Oncology, Mayo Clinic Arizona, Scottsdale, Arizona; Authors' Affiliations: 1Department of Immunology, 2Taussig Cancer Institute, and 3Glickman Urological Institute, Cleveland Clinic; 4Department of Pathology and 5Division of Hematology-Oncology, Case Western Reserve University; and 6Case Comprehensive Cancer Center, Cleveland, Ohio; and 7Division of Hematology and Oncology, Mayo Clinic Arizona, Scottsdale, Arizona Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA. Departments of Radiation Oncology and Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH. The Cleveland Clinic Taussig Cancer Institute, Cleveland, OH Vanderbilt Ingram Cancer Center , Nashville, TN, USA From the University of ChicagoMedical Center, Chicago, IL; Cancer and Leukemia Group B Statistical Center, Durham; Southeast Cancer Control Consortium Inc, CCOP, Goldsboro, NC; University of California at San Francisco, San Francisco, CA; University of Iowa, Iowa City, IA Cleveland Clinic Taussig Cancer Institute, 9500 Euclid Avenue, Mail Code R35, Cleveland, OH 44195, USA Authors' Affiliations: 1Department of Translational Hematology and Oncology Research; 2Department of Hematologic Oncology and Blood Disorders; and 3Department of Solid Tumor Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio; Authors' Affiliations: 1Department of Translational Hematology and Oncology Research; 2Department of Hematologic Oncology and Blood Disorders; and 3Department of Solid Tumor Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio Department of Medicine, Vanderbilt-Ingram Cancer Center , Nashville, TN , USA Cleveland Clinic Taussig Cancer Institute Cleveland Ohio Division of Hematology/Oncology, Medical Oncology, Taussig Cancer Institute; and Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio 3Experimental Therapeutics, Taussig Cancer Center, Cleveland Clinic, Cleveland, Ohio From Memorial Sloan Kettering Cancer Center (R.J.M.) and Pfizer (S.H.), New York; Private Medical Institution Euromedservice (K.P.) and Nonstate Health Institution Road Clinical Hospital–Russian Railways (A.V.), St. Petersburg, and the Moscow Scientific Research Oncology Institute, Moscow (B.A.) — all in Russia; the Netherlands Cancer Institute, Amsterdam (J.H.); the Cleveland Clinic, Cleveland (B.R.); Institut Gustave Roussy, Villejuif (L.A.), and Centre Léon Bérard, University of Lyon, Lyon (S.N.) —... Department of Hematology and Medical Oncology, Cleveland Clinic-Taussig Cancer Institute, Cleveland, OH 4Department of Hematology and Medical Oncology Cleveland, Clinic Taussig Cancer Institute, Cleveland, Ohio. Department of Hematology and Medical Oncology, Cleveland Clinic, Taussig Cancer Center, Cleveland, USA Division of Hematology Oncology, Vanderbilt-Ingram Cancer Center , Nashville, TN , USA Brian C. Allen, Duke University Medical Center, Durham, NC; Edward Florez, Reza Sirous, Seth T. Lirette, Michael Griswold, Candace M. Howard-Claudio, J. Clark Henegan, Judd Storrs, and Andrew D. Smith, University of Mississippi Medical Center, Jackson, MS; Erick M. Remer and Brian Rini, The Cleveland Clinic; Amit Vasanji, ImageIQ, Cleveland; Jacob E. Bieszczad, University of Toledo Medical Center, Toledo, OH; Zhen J. Wang, University of California at San Francisco Medical Center, San Francisco, CA; Kelly... Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, United States. Division of Hematology and Oncology Vanderbilt University Medical Center Nashville TN USA |
Incoming Links
Total number of triples: 126.